Press Releases | NeoGenomics Laboratories

As of November 1, 2020, we will discontinue future development for Internet Explorer

To have a better experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox. Sorry for the convenience.

Presented: February 25, 2021

NeoGenomics To Participate In The Virtual 10th Annual SVB Leerink Global Healthcare Conference

Presented: February 24, 2021

NeoGenomics Reports 18% Revenue Growth to $126 Million in the Fourth Quarter

Presented: February 24, 2021

NeoGenomics Announces CEO Succession

Presented: February 16, 2021

NeoGenomics to Participate in the BTIG Virtual Medtech, Digital Health, Life Science & Diagnostic Tools Conference

Presented: February 5, 2021

NeoGenomics Schedules its Fourth Quarter and Full Year 2020 Earnings Release for February 24, 2021

Presented: February 4, 2021

Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials

Presented: February 2, 2021

NeoGenomics and Tempus Join the Access to Comprehensive Genomic Profiling Coalition

Presented: January 6, 2021

NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes

Presented: January 5, 2021

NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes

Presented: January 4, 2021

NeoGenomics To Virtually Participate In The 39th Annual J.P. Morgan Healthcare Conference

Presented: November 9, 2020

NeoGenomics to Offer Mobile Phlebotomy Services for Liquid Biopsy Tests